Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian
GET TICKETS

Global Gene Therapy for CNS Disorders Market 2019-2023| 27% CAGR Projection Over the Next Four Years | Technavio

Share:

The global gene therapy for CNS disorders market is expected to post a
CAGR of close to 27% during the period 2019-2023, according to the
latest market research report by Technavio.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20190422005372/en/

The global gene therapy for CNS disorders market will post a CAGR of close to 27% during the period  ...

The global gene therapy for CNS disorders market will post a CAGR of close to 27% during the period 2019-2023 (Graphic: Business Wire)

The vendors that receive special drug designations for their novel gene
therapies get certain benefits including fast track approval and tax
credits. For instance, the vendors that receive orphan drug designation
get market exclusivity for ten years instead of seven years. Several
gene therapy programs have received various special designations such as
breakthrough designation and fast track designation. Regenerative
medicine advanced therapy (RMAT) is another designation given to gene
therapy programs, that provide the combined benefits of the fast track
designation and the breakthrough designation. Such developments will
lead to the growth of the market over the forecast period.

As per Technavio, the strong pipeline will have a positive impact on the
market and contribute to its growth significantly over the forecast
period. This global
gene therapy for CNS disorders market 2019-2023
research
report also analyzes other important trends and market drivers that will
affect market growth over 2019-2023.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Global gene therapy for CNS disorders market:
Strong pipeline

The market is characterized by the presence of various small and
mid-sized pharmaceuticals with novel therapies for the treatment of CNS
indications that require curative treatment. The superior efficacy of
these therapies is encouraging vendors to conduct studies and develop
their regenerative therapies for CNS indications. As a result, there is
a significant increase in the pipeline of these inhibitors, with highly
promising therapies in the late stages of clinical trials.

"The gene therapy for CNS disorders market is witnessing significant
advances in terms of technology that will help in the manufacture of
gene therapies with superior efficacy for the treatment of various CNS
indications. For instance, Zinc finger transcription factor (ZFP-TF) is
one of the novel gene therapies which helps in the regulation of genes
and binds them to the specific sequences of DNA code, to aid in the
treatment of various CNS disorders,"
says a senior research analyst
at Technavio.

Global gene therapy for CNS disorders market:
Segmentation analysis

This market research report segments the global gene therapy for CNS
disorders market by indication (SMA, and others) and geographic regions
(North America, Europe, Asia, and ROW).

The North America region led the market in 2018, followed by Europe,
Asia, and ROW respectively. The market growth in this region can be
attributed to the increasing number of novel gene therapies that are
being developed for various CNS disorders in the region.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!